| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.39 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.23 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |